Pneumonia: all 2,072 studies
Page 11 of 21. Open to participants first (286), then studies with results posted, then the rest; newest registration first within each.
- Early Use of Corticosteroids in Non-critical Patients With COVID-19 PneumoniaTerminatedNCT04451174Phase 3
- Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDSTerminatedNCT04449588Phase 2/3
- Surveillance of Non-invasive Streptococcus Pneumoniae Infections in BelgiumCompletedNCT04447521
- Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory FailureCompletedNCT04445961
- Prasugrel in Severe COVID-19 PneumoniaStatus unknownNCT04445623Phase 3
- Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 PneumoniaCompletedNCT04445272Phase 2
- Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) PneumoniaCompletedNCT04444531
- Glycine Supplement for Severe COVID-19TerminatedNCT04443673Not applicable
- Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and SeroproteomicActive, not recruitingNCT04441502
- Assessment of Lung Inflammation With FDG PET/CT in COVID-19CompletedNCT04441489
- Universal Anti-Viral Vaccine for Healthy Elderly AdultsCompletedNCT04441047Phase 1/2
- Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort StudyCompletedNCT04440124
- Glucocorticoids in COVID-19 (CORTIVID)CompletedNCT04438980Phase 3
- Trial of Antimicrobial Restraint in Presumed PneumoniaCompletedNCT04438187Not applicable
- Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)CompletedNCT04435327
- Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).TerminatedNCT04433546Phase 2
- Pathogenic Microorganisms in Adult Severe Pneumonia PatientsStatus unknownNCT04433403
- Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 PneumoniaStatus unknownNCT04433000
- Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent PlasmaTerminatedNCT04432103Phase 3
- Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 PneumoniaCompletedNCT04430023
- Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 PneumoniaWithdrawnNCT04428268Phase 2
- Early Prone Position on Coronavirus Disease 2019 PneumoniaCompletedNCT04427969
- A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）Status unknownNCT04425772Not applicable
- Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)WithdrawnNCT04425733Phase 1
- Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in QatarCompletedNCT04425382
- HFNC Treatment in COVID-19 PneumoniaCompletedNCT04424836
- Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia ProtocolStatus unknownNCT04424797Not applicable
- Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.CompletedNCT04424355
- Thrombosis Risk Assessment and Clinical Presentation of Covid-19 PneumoniaCompletedNCT04423315
- The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced PneumoniaStatus unknownNCT04422678Phase 3
- Low Dose Radiotherapy for COVID-19 PneumonitisStatus unknownNCT04420390Not applicable
- Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19CompletedNCT04420247Phase 3
- Convalescent Antibodies Infusion in COVID 19 PatientsWithdrawnNCT04418531Not applicable
- Clinical Efficacy of Nafamostat Mesylate for COVID-19 PneumoniaStatus unknownNCT04418128Phase 2/3
- PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUSCompletedNCT04416334Phase 3
- Extracellular Water in Covid 19 PneumoniaStatus unknownNCT04416009
- Echocardiography in Critically-ill Patients With COVID-19 PneumoniaStatus unknownNCT04414410
- Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad PrognosisStatus unknownNCT04414293Not applicable
- Description of Eosinophilic Pneumonia in BJI/PJI Treated by DaptomycinStatus unknownNCT04414137
- WGS-guided Tracking and Infection Control Measures of CRKPStatus unknownNCT04413305Not applicable
- Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care TherapyWithdrawnNCT04412252Phase 2
- Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia PatientsStatus unknownNCT04408378
- High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and CoagulopathyStatus unknownNCT04408235Phase 3
- Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19CompletedNCT04407468
- Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMOCompletedNCT04405973
- Hydroxychloroquine, Azithromycin in the Treatment of Covid-19Status unknownNCT04405921Phase 3
- Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center TrialCompletedNCT04405310Phase 2
- Clinical Characteristics for the Critical Ill Patients With Klebsiella Pneumoniae InfectionCompletedNCT04404582
- 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired PneumoniaCompletedNCT04403971Not applicable
- Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory MarkersTerminatedNCT04403685Phase 3
- This Study Aim is to Compare the Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis as it Was Found That Not All Patients Get Satisfying Therapeutic Effect After Taking Corticosteroids.Status unknownNCT04402177Phase 4
- Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage StudyStatus unknownNCT04401488
- Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic TrialStatus unknownNCT04399798Phase 2
- ACT-20 in Patients With Severe COVID-19 PneumoniaStatus unknownNCT04398303Phase 1/2
- Endotracheal Tube Cuff Pressure MeasurementCompletedNCT04397952
- Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)Status unknownNCT04397497Phase 2
- A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 PneumonitisStatus unknownNCT04397471
- Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe PneumoniaCompletedNCT04396522
- Low Dose Radiation Therapy for Covid-19 PneumoniaStatus unknownNCT04394793Not applicable
- Silymarin in COVID-19 PneumoniaStatus unknownNCT04394208Phase 3
- Ultra Low Doses of Therapy With Radiation Applicated to COVID-19SuspendedNCT04394182Not applicable
- Lung Irradiation for COVID-19 PneumoniaWithdrawnNCT04393948Not applicable
- Baricitinib Compared to Standard Therapy in Patients With COVID-19Status unknownNCT04393051Phase 2
- Clinical Use of Stem Cells for the Treatment of Covid-19CompletedNCT04392778Phase 1/2
- LB1148 for Pulmonary Dysfunction Associated With COVID-19 PneumoniaWithdrawnNCT04390217Phase 2
- TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial PneumoniaStatus unknownNCT04390061Phase 2
- COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo)Status unknownNCT04389385Phase 1
- COVID-19, bLOod Coagulation and ThrombosisStatus unknownNCT04388657
- Determinants of COVID-19 Pneumonia (MC-19)CompletedNCT04387799
- Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealthCompletedNCT04385901Not applicable
- Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane OxygenationSuspendedNCT04385771Not applicable
- Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe PneumoniaCompletedNCT04383535Not applicable
- Neuromuscular Electrical Stimulation in Patients With COVID19 Associated PneumoniaStatus unknownNCT04382729Not applicable
- Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia TrialWithdrawnNCT04382625Phase 4
- Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem CellsCompletedNCT04382547Phase 1/2
- COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 PneumoniaWithdrawnNCT04381923Not applicable
- Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 PneumoniaCompletedNCT04381858Phase 3
- Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in NorwayStatus unknownNCT04381247
- Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19Status unknownNCT04380818Not applicable
- Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) PneumoniaStatus unknownNCT04380376Phase 2
- LDCT in COVID-19 Pneumonia: a Prospective Moscow StudyCompletedNCT04379531Not applicable
- Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)CompletedNCT04379310
- COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19)CompletedNCT04377477Not applicable
- Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19CompletedNCT04376840Not applicable
- The Effectiveness of Hyperbaric Oxygen Therapy on Pneumonia Complicating StrokeStatus unknownNCT04376359Not applicable
- The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 PneumoniaStatus unknownNCT04374591Not applicable
- Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 PatientsStatus unknownNCT04372576
- SEVERITY SCORE FOR COVID-19 PNEUMONIAStatus unknownNCT04372199
- Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019Status unknownNCT04371601Early Phase 1
- Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )CompletedNCT04371367Phase 2
- Accuracy of Lung Ultrasound in the Diagnosis of covid19 PneumoniaStatus unknownNCT04370275
- Ozone Auto-hemotherapy for COVID-19 PneumoniaStatus unknownNCT04370223Phase 3
- Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After DischargeStatus unknownNCT04368793
- Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19CompletedNCT04368377Phase 2
- Bacteriotherapy in the Treatment of COVID-19Status unknownNCT04368351
- Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19TerminatedNCT04366791Phase 1/2
- Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute PneumopathyCompletedNCT04366752
- Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19CompletedNCT04366323Phase 1/2
- Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort StudyCompletedNCT04365764
- Protective Effect of Aspirin on COVID-19 PatientsStatus unknownNCT04365309Phase 2/3